表型化高缩性心肌病的许多面孔
Paul Geenty1, Belinda Gray2, Liza Thomas3
1Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales 2050, Australia; Department of Cardiology, Westmead Hospital, Westmead, New South Wales 2145, Australia.
Heart failure clinics
|October 13, 2025
概括
缺血性心肌病,一种遗传性心脏病,呈现出各种症状. 准确的表型识别有助于确定患者群体,以定制预后和预防心脏突发死亡.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学是一种遗传学.
- 内部医学 内部医学
背景情况:
- 增高性心肌病 (HCM) 是最常见的遗传性心肌病.
- 它的定义是左心室缩 (LVH) ≥15毫米,没有其他原因.
- HCM表现出异质的临床表型.
研究的目的:
- 强调在多变性心肌病症中准确临床表型的重要性.
- 突出各种临床表现及其对预后的影响.
- 强调风险分层的必要性,以防止心脏突然死亡.
主要方法:
- 临床数据的审查.
- 超性心肌病患者的表型分类.
- 预测因素分析. 预测因素分析.
主要成果:
- 确定了关键的临床表现,包括左心室外流通道阻塞,中心异常和心室节律失常.
- 证明不同的表型群体具有不同的自然历史.
- 突出了特定表型与心脏突然死亡风险之间的联系.
结论:
- 准确的临床表型确定对于理解多变性心肌病症至关重要.
- 现型特征能够更好地分层风险和个性化管理.
- 基于表型的有针对性的干预措施可以改善患者的治疗结果,并预防心脏突然死亡.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Cardiomyopathy I: Introduction and Classification
502
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
502
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Cardiomyopathy IV: Restrictive Cardiomyopathy
453
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
453
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K


